Search

Systrom, Hannah K, Victoria Rai, Siddharth Singh, Leonard Baidoo, Adam S Cheifetz, Shane M Devlin, Krisztina B Gecse, et al. 2025. “When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease.”. The American Journal of Gastroenterology 120 (2): 420-30.

Shah, Yash R, Angad Tiwari, Ramy Mansour, and Loren G Rabinowitz. 2024. “Sweet or Not? Azathioprine-Induced Sweet Syndrome Mimicking Erythema Nodosum in a Patient With Inflammatory Bowel Disease.”. ACG Case Reports Journal 11 (4): e01321.

Zuberi, Shaharyar A, Lauren Burdine, Jeffrey Dong, and Joseph D Feuerstein. 2024. “Representation of Racial Minorities in the United States Colonoscopy Surveillance Interval Guidelines.”. Journal of Clinical Gastroenterology 58 (8): 800-804.

Geeganage, Grace, Johanna Iturrino, Scott A Shainker, Sarah Ballou, Vikram Rangan, and Judy Nee. 2023. “Emergency Department Burden of Hyperemesis Gravidarum in the United States from 2006 to 2014.”. AJOG Global Reports 3 (1): 100166.

Weissman, Simcha, Muhammad Aziz, Ayrton Bangolo, Tamer Zahdeh, Daniel Elias, Vikas Taneja, Mohammed El-Dallal, et al. 2023. “WITHDRAWN: Non-Anti-TNF Biologics As Salvage Therapy for Refractory Acute Severe Ulcerative Colitis, A Systematic Review.”. Current Reviews in Clinical and Experimental Pharmacology.

Sengupta, Neil, Joseph D Feuerstein, Vipul Jairath, Amandeep K Shergill, Lisa L Strate, Robert J Wong, and David Wan. 2023. “Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline.”. The American Journal of Gastroenterology 118 (2): 208-31.

Gomes, Graziela S, Luiza A Frank, Renata Contri V, Maria S Longhi, Adriana R Pohlmann, and Silvia S Guterres. 2023. “Nanotechnology-Based Alternatives for the Topical Delivery of Immunosuppressive Agents in Psoriasis.”. International Journal of Pharmaceutics 631: 122535.

Papamichael, Konstantinos, Niels Vande Casteele, Bincy P Abraham, Timothy Ritter, Anjali Jain, and Adam S Cheifetz. 2023. “Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2978-2980.e2.

Dong, Jeffrey, Michelle Ladonne, and Joseph D Feuerstein. 2023. “Medicare Patients Face High Out-of-Pocket Costs for Specialty Inflammatory Bowel Disease Medications.”. The American Journal of Gastroenterology 118 (3): 481-84.

Yuan, William, Jayson S Marwaha, Shana T Rakowsky, Nathan P Palmer, Isaac S Kohane, David T Rubin, Gabriel A Brat, and Joseph D Feuerstein. 2023. “Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.”. Inflammatory Bowel Diseases 29 (5): 695-704.